Therefore, when managing ALK-positive NSCLC patients who experience SCLC transformation, it is essential to consider the patient’s overall condition, prior treatment history, and quality of life in tailoring an appropriate therapeutic plan. Here, ALK is linked to small cell lung carcinoma.